Edit |   |
---|---|
Product Name | ABT-263 |
Description | ABT-263 is a small molecule which can act as a Bcl-2 family inhibitor, Senolytic agent. It is provided as a powder. This product acts on the following biochemical pathways: Apoptosis inducer, Mitochondrial function. This product may be of interest in the following research areas and diseases: Cell death, Cancer. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 974.6 g/mol |
Size | 5 mg, 25 mg |
Concentration | n/a |
Applications | n/a |
Other Names | ABT-263, 4-[4-[[2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)- 3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]-phenyl]sulfonyl]-benzamide, Navitoclax, 923564-51-6 |
Gene, Accession, CAS # | CAS: 923564-51-6 |
Catalog # | abx282874 |
Price | please inquire |
Order / More Info | ABT-263 from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950